E-LIB Suche - Ergebnisse für: Boormans, J. L.

1

Oncologic outcomes in patients with variant histologies of ..:

Pallauf, M. ; Fletcher, S.A. ; Rezaee, M....
European Urology. 85 (2024) - p. S369-S370 , 2024

Link: https://doi.org/10.1016/..

2

A comparison of the incidence of 90-days complications in p..:

van Ginkel, N. ; Meijer, D. ; Nieuwenhuijzen, J....
European Urology Open Science. 57 (2023) - p. S316 , 2023

Link: https://doi.org/10.1016/..

3

Nation-wide progression outcomes after BCG therapy for high..:

Pijpers, O.M. ; Van Hoogstraten, L.M.C. ; De Beijert, I....
European Urology. 83 (2023) - p. S403-S404 , 2023

Link: https://doi.org/10.1016/..

4

A composite biomarker approach to spare neoadjuvant chemoth..:

De Jong, J.J. ; Robertson, A.G. ; Beije, N....
European Urology. 83 (2023) - p. S1529 , 2023

Link: https://doi.org/10.1016/..

5

Sequential intravesical Gemcitabine and Docetaxel as salvag..:

Pijpers, O.M. ; De Jong, J.J. ; Zee, J.Y....
European Urology. 83 (2023) - p. S1025 , 2023

Link: https://doi.org/10.1016/..

6

Induction therapy with ipilimumab and nivolumab followed by..:

Stockem, C.F. ; Mellema, J.J.J. ; van Rhijn, B.W.G....
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

The CHASIT study: sequential chemo-immunotherapy in patient..:

Rutten, V. C. ; Salhi, Y. ; Robbrecht, G. J....
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

8

Protein-based molecular subtypes associate with clinical-pa..:

Bahlinger, V. ; Angeloni, M. ; Cabanas, M.F.L....
European Urology. 83 (2023) - p. S1693-S1694 , 2023

Link: https://doi.org/10.1016/..

9

Comparing oncological and perioperative outcomes of open ve..:

Grossmann, N.C. ; Soria, F. ; Juvet, T....
European Urology. 83 (2023) - p. S737-S738 , 2023

Link: https://doi.org/10.1016/..

10

Disease-Free Survival of Patients with Muscle Invasive Blad..:

Bruck, K. ; Meijer, R.P. ; Boormans, J.L....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 3 - p. e204 , 2022

Link: https://doi.org/10.1016/..

11

Validation and reliability of the Dutch version of the EORT..:

Ripping, T. M. ; Rammant, E. ; Witjes, J. A....
Health and Quality of Life Outcomes. 20 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

A urine-based molecular assay refines the risk stratificati..:

De Jong, J.J. ; Pijpers, O.M. ; Kessel, K.E.M....
European Urology. 81 (2022) - p. S357 , 2022

Link: https://doi.org/10.1016/..

13

Non-muscle invasive bladder cancer subtypes with differenti..:

De Jong, F.C. ; Laajala, T.D. ; Hoedemaeker, R.F....
European Urology. 81 (2022) - p. S105-S106 , 2022

Link: https://doi.org/10.1016/..

14

Circulating tumour cells to drive the use of neoadjuvant ch..:

Beije, N. ; de Kruijff, I.E. ; de Jong, J.J....
ESMO Open. 7 (2022) 2 - p. 100416 , 2022

Link: https://doi.org/10.1016/..

15

A multicenter cohort of patients treated with concurrent ch..:

De Ruiter, B. ; Van De Kamp, M.W. ; Van Steenbergen, J.P.Z....
European Urology. 81 (2022) - p. S1333-S1334 , 2022

Link: https://doi.org/10.1016/..